Novozymes Biopharma DK A/S — Credit Rating and Financial Key Figures

Novozymes Biopharma DK A/S (CVR number: 29603537) is a company from GLADSAXE. The company recorded a gross profit of 911.8 kDKK in 2023. The operating profit was 911.8 kDKK, while net earnings were 14.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was 9.7 %, which can be considered good but Return on Equity (ROE) was 7.6 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 94.1 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Novozymes Biopharma DK A/S's liquidity measured by quick ratio was 17 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.